Concentriq® delivers value. Proscia delivers trust.
The 2024 KLAS Emerging Company Spotlight recognizes Concentriq as a digital pathology software that overcomes diagnostic challenges and improves lab efficiency.
Download your complimentary copy to get more details.
STUDY REPORT
Quest Diagnostics Feasibility Study Conducted with Proscia and Ibex Medical Analytics
Learn how AI-powered diagnostics, delivered through an enterprise digital pathology platform, impacted operations in a large diagnostic lab setting. Dive into study goals, methodology, and results, and get the details on how deeply integrated AI-powered workflows allowed pathologists to sign out 2.9 cases per hour instead of 1.2.
VISIONARIES TRUST OUR VISION
See why visionary lab leaders choose to partner with Proscia.
How Philadelphia startup Proscia is bringing cancer biopsies into the digital age
The company’s Concentriq AP Dx software allows pathologists to make a primary diagnosis from an image on their computer screen, rather than a glass slide.
Comprehensive primary diagnostic workflows for high-throughput laboratories
Modern pathology is far more than a stellar user experience. Concentriq Dx helps pathologists improve productivity with easier access to data, and allows labs to reach full digitization with an AI-ready platform that delivers higher-quality diagnostic services.
- All the viewing tools you need, including annotations, cell counter, grid views, viewing trail map, image filters, multi-view and more.
- Efficiently organize your day with a worklist, case tags, sorting, and dynamic, multi-facet search and filter functionality
- Complete data access throughout your workflow including critical diagnostics fields, LIS integration, Image Analysis integration, and intuitive slide trays.
Seamless collaboration across global networks
We’ve made it easier than ever to overcome the impacts of a global pathologist shortage by simplifying and streamlining working with peers – regardless of time or location.
- Feature-rich collaboration to suit every user. LIVE collaboration mode allows an unlimited number of users to collaborate in real-time. View users as they review cases and annotate in real-time, or “follow” a leader during case review with persistent chat to record important conversations. Asynchronous collaboration allows pathologists to easily collaborate without aligning busy schedules.
- Simplified tumor boards and peer reviews. Case tagging, advanced search, and filtering makes it fast and easy to identify and pull together cases for group review.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id, mattis vel, nisi. Sed pretium, ligula sollicitudin laoreet viverra, tortor libero sodales leo, eget blandit nunc tortor eu nibh. Nullam mollis. Ut justo. Suspendisse potenti.
Sed egestas, ante et vulputate volutpat, eros pede semper est, vitae luctus metus libero eu augue. Morbi purus libero, faucibus adipiscing, commodo quis, gravida id, est. Sed lectus. Praesent elementum hendrerit tortor. Sed semper lorem at felis. Vestibulum volutpat, lacus a ultrices sagittis, mi neque euismod dui, eu pulvinar nunc sapien ornare nisl. Phasellus pede arcu, dapibus eu, fermentum et, dapibus sed, urna.
Morbi interdum mollis sapien. Sed ac risus. Phasellus lacinia, magna a ullamcorper laoreet, lectus arcu pulvinar risus, vitae facilisis libero dolor a purus. Sed vel lacus. Mauris nibh felis, adipiscing varius, adipiscing in, lacinia vel, tellus. Suspendisse ac urna. Etiam pellentesque mauris ut lectus. Nunc tellus ante, mattis eget, gravida vitae, ultricies ac, leo. Integer leo pede, ornare a, lacinia eu, vulputate vel, nisl.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id, mattis vel, nisi. Sed pretium, ligula sollicitudin laoreet viverra, tortor libero sodales leo, eget blandit nunc tortor eu nibh. Nullam mollis. Ut justo. Suspendisse potenti.
Sed egestas, ante et vulputate volutpat, eros pede semper est, vitae luctus metus libero eu augue. Morbi purus libero, faucibus adipiscing, commodo quis, gravida id, est. Sed lectus. Praesent elementum hendrerit tortor. Sed semper lorem at felis. Vestibulum volutpat, lacus a ultrices sagittis, mi neque euismod dui, eu pulvinar nunc sapien ornare nisl. Phasellus pede arcu, dapibus eu, fermentum et, dapibus sed, urna.
Morbi interdum mollis sapien. Sed ac risus. Phasellus lacinia, magna a ullamcorper laoreet, lectus arcu pulvinar risus, vitae facilisis libero dolor a purus. Sed vel lacus. Mauris nibh felis, adipiscing varius, adipiscing in, lacinia vel, tellus. Suspendisse ac urna. Etiam pellentesque mauris ut lectus. Nunc tellus ante, mattis eget, gravida vitae, ultricies ac, leo. Integer leo pede, ornare a, lacinia eu, vulputate vel, nisl.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id, mattis vel, nisi. Sed pretium, ligula sollicitudin laoreet viverra, tortor libero sodales leo, eget blandit nunc tortor eu nibh. Nullam mollis. Ut justo. Suspendisse potenti.
Sed egestas, ante et vulputate volutpat, eros pede semper est, vitae luctus metus libero eu augue. Morbi purus libero, faucibus adipiscing, commodo quis, gravida id, est. Sed lectus. Praesent elementum hendrerit tortor. Sed semper lorem at felis. Vestibulum volutpat, lacus a ultrices sagittis, mi neque euismod dui, eu pulvinar nunc sapien ornare nisl. Phasellus pede arcu, dapibus eu, fermentum et, dapibus sed, urna.
Morbi interdum mollis sapien. Sed ac risus. Phasellus lacinia, magna a ullamcorper laoreet, lectus arcu pulvinar risus, vitae facilisis libero dolor a purus. Sed vel lacus. Mauris nibh felis, adipiscing varius, adipiscing in, lacinia vel, tellus. Suspendisse ac urna. Etiam pellentesque mauris ut lectus. Nunc tellus ante, mattis eget, gravida vitae, ultricies ac, leo. Integer leo pede, ornare a, lacinia eu, vulputate vel, nisl.
Algorithms
Access Proscia’s Precision Medicine AI Portfolio
“By integrating H-optimus-0 into Concentriq Embeddings, Proscia’s users now have access to a powerful tool that accelerates AI model development and drives breakthroughs not only in precision medicine, but also for therapeutic research and development.”
David Cahané, Co-Founder and General Manager at Bioptimus
Get a full view of the Concentriq enterprise pathology platform through these webinars.
Get a full view of the Concentriq enterprise pathology platform through these webinars.
Webinar
Quest Diagnostics, Ibex, and Proscia: Quantifying the Value of AI-Powered Digital Workflows in Real-World Diagnostic Laboratories
On-Demand Webinar
Transforming precision programs with pathology RWD
Leaders from Genentech and PathGroup discuss how the digitization of pathology has generated a wealth of untapped data that is driving the next breakthroughs in precision medicine drug discovery and development. Watch the webinar and learn about:
- The value of RWD in accelerating critical milestones
- The future impact of RWD on precision medicine as digital pathology adoption continues to rise
- The role clinical laboratories play in advancing the novel diagnostics and therapies of tomorrow
Learn how innovators in life sciences R&D, clinical trials, and diagnostics are unlocking the full potential of pathology for precision medicine.
Access the Precision Medicine AI Portfolio on the Concentriq Platform
The Concentriq enterprise pathology platform empowers pathologists and scientists to harness the full potential of digital pathology and AI by providing access to the most extensive portfolio of applications available on the market today.
Access Proscia’s Precision Medicine AI Portfolio
Please let us know which applications you’re looking to add to your workflow. Preferred Applications are available for purchase directly through Proscia. Speak with one of our experts for more information.
FEATURED REPORT
Rewiring Pathology for Precision Drug Discovery and Development
Biopharma leaders are no longer asking if they should invest in digital pathology and AI — they’re scaling it enterprise-wide to accelerate R&D and sharpen their competitive advantage. Through a series of case studies, discover how biopharma companies are using digital pathology and AI to transform precision drug development in five key areas.
Accordion Headline
Accordion Title 1
Accordion Content 1
Accordion Title 2
Accordion Content 2
Left
Lorem ipsum dolor sit amet consectetur.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Donec odio. Quisque volutpat mattis eros.
Right
Lorem ipsum dolor sit amet consectetur.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Donec odio. Quisque volutpat mattis eros.